MML Investors Services
LGND icon

MML Investors Services’s Ligand Pharmaceuticals LGND Stock Holding History

MML Investors Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
3,426
+137
+4% +$32.3K ﹤0.01% 1970
2026
Q1 		$657K Sell
3,289
-445
-12% -$88K ﹤0.01% 2052
2025
Q4 		$706K Sell
3,734
-228
-6% -$43.8K ﹤0.01% 2018
2025
Q3 		$702K Buy
3,962
+467
+13% +$69.4K ﹤0.01% 1955
2025
Q2 		$397K Buy
3,495
+351
+11% +$37.5K ﹤0.01% 2239
2025
Q1 		$331K Buy
3,144
+680
+28% +$76.9K ﹤0.01% 2253
2024
Q4 		$264K Buy
2,464
+370
+18% +$41.8K ﹤0.01% 2339
2024
Q3 		$210K Buy
+2,094
New +$211K ﹤0.01% 2417
2019
Q4 		– Sell
-3,527
Closed -$219K – 1531
2019
Q3 		$219K Buy
+3,527
New +$221K ﹤0.01% 1359
2019
Q2 		– Sell
-2,868
Closed -$225K – 1632
2019
Q1 		$225K Hold
2,868
– – ﹤0.01% 1422
2018
Q4 		$243K Buy
2,868
+678
+31% +$72.3K ﹤0.01% 1273
2018
Q3 		$375K Buy
2,190
+324
+17% +$48.8K 0.01% 1163
2018
Q2 		$241K Sell
1,866
-1,082
-37% -$121K 0.01% 1182
2018
Q1 		$304K Buy
+2,948
New +$292K 0.01% 1062

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MML Investors Services's LGND Position: Q2 2026 in Review

MML Investors Services increased its Ligand Pharmaceuticals (LGND) stake by 4.2% in Q2 2026, buying an estimated $32.3K and bringing the position to 3,426 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

MML Investors Services first reported a position in LGND in Q1 2018 and has held it in 14 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • MML Investors Services held 3,426 shares of Ligand Pharmaceuticals worth $1.08M as of Q2 2026.
  • MML Investors Services bought 137 Ligand Pharmaceuticals shares in Q2 2026, an estimated $32.3K.
  • Ligand Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1970 holding.
  • MML Investors Services first reported a position in Ligand Pharmaceuticals in Q1 2018 and has held it in 14 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.